within Pharmacolibrary.Drugs.ATC.N;

model N01AB01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00011666666666666667,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0014,
    k12             = 12,
    k21             = 12
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N01AB01</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Halothane is a volatile, inhalation general anesthetic historically used for the induction and maintenance of general anesthesia. Due to associated hepatotoxicity and the availability of safer alternatives, its clinical use has significantly declined and it is no longer commonly employed in most countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics parameters reported for healthy adults undergoing anesthesia with halothane.</p><h4>References</h4><ol><li><p>Larson, CP (2021). Scientific Accuracy Matters. <i>Anesthesiology</i> 135(4) 724–727. DOI:<a href=&quot;https://doi.org/10.1097/ALN.0000000000003952&quot;>10.1097/ALN.0000000000003952</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34499097/&quot;>https://pubmed.ncbi.nlm.nih.gov/34499097</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N01AB01;
